Product Details for ANDA 217692
LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
1%
Marketing Status: Prescription
1%
Marketing Status: Prescription
2%
Marketing Status: Prescription
1%
Marketing Status: Prescription
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1%
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A217692
Product Number: 001
Approval Date: Jun 16, 2023
Applicant Holder Full Name: MANKIND PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1%
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A217692
Product Number: 001
Approval Date: Jun 16, 2023
Applicant Holder Full Name: MANKIND PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
1%
Marketing Status: Prescription
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1%
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A217692
Product Number: 003
Approval Date: Nov 29, 2023
Applicant Holder Full Name: MANKIND PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1%
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A217692
Product Number: 003
Approval Date: Nov 29, 2023
Applicant Holder Full Name: MANKIND PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
2%
Marketing Status: Prescription
Active Ingredient: LIDOCAINE HYDROCHLORIDE
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A217692
Product Number: 002
Approval Date: Jun 16, 2023
Applicant Holder Full Name: MANKIND PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: LIDOCAINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2%
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A217692
Product Number: 002
Approval Date: Jun 16, 2023
Applicant Holder Full Name: MANKIND PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information